- Home
- Publications
- Publication Search
- Publication Details
Title
A Therapeutic Peptide Vaccine Against PCSK9
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-09-26
DOI
10.1038/s41598-017-13069-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2017 Taiwan lipid guidelines for high risk patients
- (2017) Yi-Heng Li et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine strategies for lowering LDL by immunization against proprotein convertase subtilisin/kexin type 9
- (2016) Bryce Chackerian et al. CURRENT OPINION IN LIPIDOLOGY
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients
- (2016) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ATRQβ-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice
- (2016) Yanzhao Zhou et al. JOURNAL OF HYPERTENSION
- Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy
- (2015) Dan Ding et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- A cholesterol-lowering VLP vaccine that targets PCSK9
- (2015) Erin Crossey et al. VACCINE
- Therapeutic Vaccines for Hypertension and Dyslipidemia
- (2014) Hironori Nakagami et al. International Heart Journal
- Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management
- (2014) Gergana Galabova et al. PLoS One
- Effectiveness and Safety of a Therapeutic Vaccine Against Angiotensin II Receptor Type 1 in Hypertensive Animals
- (2012) Xiao Chen et al. HYPERTENSION
- An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes
- (2012) Liwen Zhang et al. International Journal of Biological Sciences
- Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters
- (2010) Bin Dong et al. JOURNAL OF LIPID RESEARCH
- “Self-Nonself” Peptides in the Design of Vaccines
- (2009) Darja Kanduc CURRENT PHARMACEUTICAL DESIGN
- Hepatocyte Nuclear Factor 1α Plays a Critical Role inPCSK9Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
- (2009) Hai Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects
- (2008) Darja Kanduc EXPERT OPINION ON BIOLOGICAL THERAPY
- Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study
- (2008) Alain C Tissot et al. LANCET
- Molecular basis for LDL receptor recognition by PCSK9
- (2008) H. J. Kwon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More